Copyright
©The Author(s) 2024.
World J Crit Care Med. Sep 9, 2024; 13(3): 96132
Published online Sep 9, 2024. doi: 10.5492/wjccm.v13.i3.96132
Published online Sep 9, 2024. doi: 10.5492/wjccm.v13.i3.96132
Table 1 Demographic parameters, mortality scores, mechanical ventilation and outcome
Parameters | Group | P value | ||
Low T3 | Low T3T4 | |||
Age in years | 64.8 ± 9.7 | 62.1 ± 15.9 | 0.483 | |
Sex | Male | 12 (50) | 10 (43.5) | 0.765 |
Female | 12 (50) | 13 (56.5) | ||
BMI | 25.8 ± 5.4 | 26.6 ± 5.4 | 0.712 | |
APACHE II | 18.8 ± 6.9 | 20.8 ± 7.7 | 0.398 | |
SAPS II | 52.5 ± 13.1 | 59.0 ± 15.5 | 0.046 | |
SOFA | 10.6 ± 2.8 | 10.6 ± 4.6 | 0.857 | |
Outcome | ||||
Discharge | 16 (66.6) | 11 (47.8) | 0.125 | |
Death | 8 (33.3) | 12 (52.1) | ||
ICU stay in days | 13.6 ± 25.0 | 22.0 ± 21.0 | 0.837 | |
MV in days | 9.5 ± 3.1 | 15.4 ± 19.3 | 0.906 |
Table 2 Vasopressor requirement and complications according to the groups
Parameters | Group | P value | ||
Low T3 | Low T3T4 | |||
Vasopressors, No/Yes (%) | ||||
Norepinephrine | 0/24 (0.0/100.0) | 0/23 (0.0/100.0) | Constant | |
Vasopressin | 9/15 (37.2/62.5) | 12/11 (54.2/45.8) | 0.311 | |
Dobutamine | 14/10 (58.3/41.7) | 4/19 (17.4/82.6) | 0.003 | |
Epinephrine | 18/6 (75.0/25.0) | 4/19 (17.4/82.6) | 0.000 | |
Complications, No/Yes (%) | ||||
Pneumonia | 19/5 (79.2/20.8) | 16/7 (69.6/30.4) | 0.450 | |
ARDS | 16/8 (66.7/33.3) | 15/8 (65.2/34.8) | 0.916 | |
Renal failure | 20/4 (83.3/16.7) | 7/16 (30.4/69.6) | 0.000 | |
Liver failure | 18/6 (75.0/25.0) | 20/3 (87.0/13.0) | 0.297 | |
MOF | 19/5 (79.2/20.8) | 6/17 (26.1/73.9) | 0.000 |
Table 3 Blood count, thyroid hormones and albumin values according to the groups
Parameter | Time | Group | P value | ||
Low T3 | Low T3T4 | 95%CI | |||
Leukocytes as × 109/L, median | T0 | 15.66 | 11.21 | 0.15 to 0.16 | 0.200 |
T1 | 10.51 | 13.34 | 0.81 to 0.83 | 0.220 | |
T2 | 10.15 | 13.54 | 0.61 to 0.63 | 0.082 | |
Erythrocytes as × 109/L, median | T0 | 4.21 | 4.01 | 0.46 to 0.48 | 0.231 |
T1 | 3.96 | 3.81 | 0.61 to 0.63 | 0.216 | |
T2 | 3.78 | 2.85 | 0.53 to 0.51 | 0.335 | |
Platelets as × 109/L, median | T0 | 227.00 | 147.00 | 0.08 to 0.10 | 0.206 |
T1 | 209.00 | 142.00 | 0.24 to 0.26 | 0.180 | |
T2 | 180.00 | 180.50 | 0.36 to 0.38 | 0.160 | |
TSH in mIU/L, median | T0 | 1.30 | 0.88 | 0.24 to 0.25 | 0.246 |
T1 | 1.01 | 0.78 | 0.73 to 0.75 | 0.755 | |
T2 | 1.18 | 1.00 | 0.40 to 0.42 | 0.417 | |
FT3 in pmol/L, median | T0 | 3.99 | 3.52 | 0.20 to 0.22 | 0.206 |
T1 | 4.64 | 4.72 | 0.92 to 0.93 | 0.929 | |
T2 | 6.35 | 4.75 | 0.34 to 0.36 | 0.354 | |
FT4 in pmol/L), median | T0 | 17.30 | 9.20 | 0.00 to 0.00 | 0.000 |
T1 | 17.35 | 10.70 | 0.02 to 0.03 | 0.035 | |
T2 | 15.15 | 11.40 | 0.05 to 0.06 | 0.064 | |
Albumin in g/L, mean ± SD | T0 | 27.29 ± 4.57 | 27.74 ± 4.64 | -4.17 to 1.58 | 0.372 |
T1 | 28.46 ± 3.29 | 27.39 ± 3.88 | -4.40 to 0.15 | 0.131 | |
T2 | 29.75 ± 2.91 | 28.17 ± 6.41 | -3.89 to -0.23 | 0.047 |
Table 4 Inflammatory parameters and blood gas analyzes
Parameter | Time | Group | P value | ||
Low T3 | Low T3T4 | 95%CI | |||
Median | |||||
Neutrophils 1 | T | 0.88 | 0.86 | 0.29-0.31 | 0.300 |
T1 | 0.88 | 0.85 | 0.19-0.21 | 0.391 | |
T2 | 0.86 | 0.82 | 0.03-0.04 | 0.038 | |
Lymphocytes 1 | T0 | 0.05 | 0.05 | 0.45-0.47 | 0.464 |
T1 | 0.06 | 0.07 | 0.17-0.19 | 0.182 | |
T2 | 0.01 | 0.09 | 0.01-0.02 | 0.013 | |
CRP in mg/dL | T0 | 89.00 | 106.00 | 0.92-0.93 | 0.923 |
T1 | 145.50 | 153.00 | 0.54-0.56 | 0.559 | |
T2 | 119.00 | 77.60 | 0.08-0.09 | 0.436 | |
PCT in ng/mL | T0 | 3.85 | 5.88 | 0.44-0.46 | 0.452 |
T1 | 7.55 | 4.27 | 0.29-0.31 | 0.310 | |
T2 | 2.47 | 5.50 | 0.50-0.52 | 0.492 | |
pH | T0 | 7.35 | 7.33 | 0.44-0.46 | 0.459 |
T1 | 7.31 | 7.39 | 0.28-0.29 | 0.287 | |
T2 | 7.35 | 7.46 | 0.14-0.15 | 0.149 | |
pCO2 in kPa | T0 | 5.52 | 5.06 | 0.18-0.19 | 0.198 |
T1 | 5.19 | 5.59 | 0.30-0.32 | 0.318 | |
T2 | 5.82 | 5.10 | 0.85-0.86 | 0.864 | |
pO2 in kPa | T0 | 11.73 | 12.10 | 0.44-0.46 | 0.448 |
T1 | 10.39 | 13.59 | 0.82-0.84 | 0.829 | |
T2 | 9.59 | 12.10 | 0.92-0.93 | 0.929 | |
HCO3 in mmol/L | T0 | 21.45 | 21.00 | 0.43-0.45 | 0.439 |
T1 | 20.70 | 23.25 | 0.65-0.67 | 0.663 | |
T2 | 22.70 | 23.70 | 0.41-0.43 | 0.413 | |
Lactate in mmol/L | T0 | 3.70 | 2.50 | 0.40-0.41 | 0.409 |
T1 | 2.50 | 1.85 | 0.14-0.16 | 0.146 | |
T2 | 2.00 | 2.55 | 0.01-0.02 | 0.013 |
Table 5 Vasoactive drug-dependent index, shock index and inflammatory prognostic scores
Parameter | Time | Group | P value | ||
Low T3 | Low T3T4 | 95%CI | |||
VDI | T0 | 0.11 | 0.13 | 0.65-0.67 | 0.655 |
T1 | 0.03 | 0.06 | 0.41-0.43 | 0.419 | |
T2 | 0.00 | 0.00 | 0.93-0.94 | 0.934 | |
SI | T0 | 1.21 | 0.00 | 0.31-0.33 | 0.322 |
T1 | 0.75 | 0.86 | 9.14-0.15 | 0.148 | |
T2 | 0.70 | 0.79 | 0.32-0.34 | 0.329 | |
NLR | T0 | 15.00 | 12.00 | 0.29-0.31 | 0.298 |
T1 | 15.00 | 13.00 | 0.21-0.23 | 0.218 | |
T2 | 12.00 | 7.00 | 0.03-0.04 | 0.037 | |
PLR | T0 | 30.55 | 21.09 | 0.26-0.28 | 0.550 |
T1 | 30.26 | 20.20 | 0.17-0.18 | 0.483 | |
T2 | 23.40 | 20.00 | 0.50-0.52 | 0.496 | |
PI | T0 | 42.52 | 60.78 | 0.20-0.22 | 0.206 |
T1 | 69.14 | 55.71 | 0.21-0.23 | 0.225 | |
T2 | 82.10 | 29.98 | 0.05-0.06 | 0.129 |
- Citation: Kovacevic M, Nesek-Adam V, Klokic S, Mujaric E. Low T3 vs low T3T4 euthyroid sick syndrome in septic shock patients: A prospective observational cohort study. World J Crit Care Med 2024; 13(3): 96132
- URL: https://www.wjgnet.com/2220-3141/full/v13/i3/96132.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v13.i3.96132